Skip to main content
. 2012 Jun 15;7:40. doi: 10.1186/1750-1172-7-40

Table 3.

Characteristics of patients with surfactant disorders

Patient number Sex Age at diagnosis (years) Follow up (years) Surfactant disorder Mutation
1*
M
0.3
2.9
SP-C
c.424delC
2*
M
0.4
3.6
SP-C
c.566 G > A (C189Y)
3*
F
0.3
3.8
SP-C
c.566 G > A (C189Y)
4*
M
0.2
1.4
SP-C
c.325-1 G > A
5*
M
2.4
0.4
SP-C
c.218 T > C (I73T)
6*
F
5.8
0
SP-C
c.218 T > C (I73T)
7*
F
1.6
2.4
SP-C
c.218 T > C (I73T)
8*
F
0.4
1.4
SP-C
c.218 T > C (I73T)
9*
F
1.2
1.2
SP-C
c.218 T > C (I73T)
10*
M
0.8
2.5
SP-C
c.218 T > C (I73T)
11*
F
0.3
4.2
SP-C
c.218 T > C (I73T)
12*
F
0
1.8
SP-C
c.218 T > C (I73T)
13*
M
1.6
md
SP-C
c.218 T > C (I73T)
14*
M
0.7
4.2
SP-C
c.218 T > C (I73T)
15*
M
2.2
3.1
SP-C
c.218 T > C (I73T)
16*
F
0.2
6.2
SP-C
c.218 T > C (I73T)
17*
F
2.7
11.7
SP-C
c.218 T > C (I73T)
18*
F
0.5
12.4
SP-C
c.218 T > C (I73T)
19*
M
0.4
6.6
SP-C
c.218 T > C (I73T)
20*
M
0.3
2.4
SP-C
c.581 T > C (L194P)
21*
M
8.5
0
SP-C
c.563 T > C (L188P)
22*
F
0.4
17.2
SP-C
c.116 T > C (V39A)
23
M
0
0.1
SP-B
g.1549 C > GAA (121ins2) −/−
24
M
0
0.1
SP-B
g.1549 C > GAA (121ins2) −/−
25
M
0.2
0
SP-B
g.1549 C > GAA (121ins2) −/−
26
F
0
0.2
SP-B
g.1549 C > GAA (121ins2) −/−
27
M
0.1
0
SP-B
c.496delG −/−
28
M
0
0.1
SP-B
Y253X −/−
29
F
0
0.2
SP-B
672 + 2del5 −/−
30*
F
0
9.2
ABCA3
c.3518 C > G (T1173R) −/−
31*
M
0.3
10.9
ABCA3
c.757 G > C (D253H) −/−
32*
F
2.3
MD
ABCA3
c.3518 C > G (T1173R) −/−
33*
M
0.3
3.4
ABCA3
P585 −/−
34*
F
12.3
3
ABCA3
c.3518 C > G (T1173R) −/−
35*
F
0.1
4.8
TTF1
c.786_787del2 (p.L263fs)
36*
F
0.1
1.5
TTF1
c.493 C > T(R165W)
  Sex ratio 1 Median 0.3 Median 2.4    

* Published patients.

Abbreviations: M: male. F: female. MD: missing data.